Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRIW) Net Cash Flow (2020 - 2025)

Biofrontera has reported Net Cash Flow over the past 6 years, most recently at $2.9 million for Q4 2025.

  • Quarterly results put Net Cash Flow at $2.9 million for Q4 2025, down 3.17% from a year ago — trailing twelve months through Dec 2025 was -$8.1 million (down 276.42% YoY), and the annual figure for FY2025 was $448000.0, down 90.18%.
  • Net Cash Flow for Q4 2025 was $2.9 million at Biofrontera, up from -$3.8 million in the prior quarter.
  • Over the last five years, Net Cash Flow for BFRIW hit a ceiling of $22.8 million in Q4 2021 and a floor of -$10.4 million in Q4 2022.
  • Median Net Cash Flow over the past 5 years was -$1.8 million (2023), compared with a mean of -$1.0 million.
  • Biggest five-year swings in Net Cash Flow: surged 526.51% in 2021 and later tumbled 10894.68% in 2023.
  • Biofrontera's Net Cash Flow stood at $22.8 million in 2021, then crashed by 145.37% to -$10.4 million in 2022, then surged by 79.88% to -$2.1 million in 2023, then skyrocketed by 245.49% to $3.0 million in 2024, then dropped by 3.17% to $2.9 million in 2025.
  • The last three reported values for Net Cash Flow were $2.9 million (Q4 2025), -$3.8 million (Q3 2025), and -$3.1 million (Q2 2025) per Business Quant data.